Kyongbo Pharmaceutical Co., Ltd. was founded in 1987. Since then, with our experience in manufacturing various APIs, we have become the No.1 API manufacturer in Korea.
Now, there are seven API production workshops at Asan in Korea. With them, we have accumulated expertise and experience in API
read moreproduction to implement projects of new drug joint-development and CMO·CDMO business implementing non-clinical and clinical research of phase I, II, III to commercial production.
Kyongbo has specialized plants and quality systems to manufacture APIs qualified to meet cGMP standards. Also, it has gone through regular audits and approval from USFDA, EDQM, PMDA, and KFDA.
Moreover, with personnel with accumulated experience and great expertise, the CMO Business Unit (CBU) of Kyongbo has been focusing on and implementing a variety of CMO · CDMO projects, expanding our business globally. This team enables communication and quick response with our clients effectively.
It possesses a variety of manufacturing facilities and analytical equipment (NMR, PXRD, HPLC, UPLC, FT-IR, UV-Vis, LC (GC)-ass, ICP, DSC, TGA, PSD, SEM, Electron Microscope, etc.) to develop and manufacture a high-quality large and small amount of APIs.
Kyongbo can service;
- Process Development & Optimization
- Test Method Development & Validation
- Technical Transfer Process for Safety and Control Quality with PAT Tools
- Lab, Pilot (<50L) and Full-scale (300L~12,000L) APIs Manufacturing
- High-potency (Cytotoxic & non-Cytotoxic APIs) Plant